Navigation Links
Promising One-of-a-kind Clinical Trial Adds Immunotherapy to Colorectal Cancer Treatment Protocol
Date:8/31/2017

A first-of-its-kind clinical study may offer new hope to patients battling rectal cancer.

The Phase 2 study, newly underway at Providence Cancer Center, is led by Kristina Young, M.D., Ph.D., who was recognized in 2016 as one of 15 most promising young researchers in the nation by the Sidney Kimmel Foundation for Cancer Research.

The trial is open to patients with Stage 2 and higher rectal cancer who are slated to undergo the standard treatment of radiation and chemotherapy prior to surgery. The clinical trial adds an additional component to the pre-surgery radiation/chemotherapy regimen – immunotherapy. It is administered in the form of daily pills for two weeks prior to radiation and chemotherapy, and then during that treatment as well.

Radiation and chemotherapy treatments are given prior to surgery with the hope they will shrink the tumor slightly. Dr. Young’s pre-clinical research suggests adding the immunotherapy protocol will increase shrinkage of the tumor. Young is working with Galunisertib, a drug under development by Eli Lilly and Company. She describes the drug as helping the body rev up the immune system to fight the cancer.

The first three patients to participate in the clinical trial have shown a “dramatic response,” according to Dr. Young. One patient’s tumor completely disappeared, while the two other patients had more than a 75 percent decrease in tumor size, with equally impressive responses in the lymph nodes.

“These initial responses are very exciting and make us hopeful that this therapy will improve outcomes for this deadly disease,” said Dr. Young.

The Phase 2 clinical trial will enroll 50 patients. If the tumors of at least 18 patients disappear, that would more than double the typical response of chemotherapy and radiation, and would be seen as contributing to the success of the trial.

This trial is a continuation of Dr. Young’s post-doctoral work on modifying the tumor microenvironment in combination with radiation to improve the outcome for patients with rectal cancer. When Dr. Young was honored with the Kimmel Scholar Award last year, the recognition came with a two-year, $200,000 grant to further her work on harnessing the patient’s own immune system to eradicate cancer. The funding allowed her to further investigate each patient’s immune response to their tumor while enrolled in this trial. This particular type of immunotherapy has great potential for use across many tumor types. “We are working on writing clinical trials in breast and head and neck cancer, which have shown promising results in the lab,” said Dr. Young.

Learn more about the clinical trial here or call 503-215-2614.

Dr. Young is a radiation oncologist with The Oregon Clinic and an Assistant Member at the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14644140.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Pharmalto Named One of the “20 Most Promising Healthcare Solution Providers 2017” by CIOReview Magazine
2. United States Surgeon General, Dr. Vivek Murthy, Shares what Fuels his Uncompromising Commitment to a Healthier Nation in Mediaplanet’s “Careers in Health Care” Campaign
3. Compliancy Group Named One of Healthcare Tech Outlook's 10 Most Promising Healthcare Compliance Solution Providers 2016
4. CloudLIMS named in 20 Most Promising Pharma and Life Sciences Tech Solution Providers 2016 by CIOReview
5. DataPoint Named on List of 20 Most Promising SharePoint Solution Providers
6. Personalized Learning Study’s “Promising” Claims Diminished by Limited Evidence and Weak Generalizability, Says New NEPC Review
7. The Center for Advancing Innovation and The Medical Center of the Americas Partner to Launch the SPACE RACE to Advance Promising NASA Inventions
8. Mesothelioma Experts Focus on Promising Immunotherapy Drug in New Article, According to Surviving Mesothelioma
9. CIOReview Selects Smartlink Mobile Systems for 50 Most Promising Healthcare Solution Providers 2015
10. Promising New Antimicrobials Could Fight Drug-Resistant MRSA Infection, New Georgia State Study Finds
11. Newly-Published Review of Promising Mesothelioma Drug Finds Value Questions Remain, According to Surviving Mesothelioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2018)... ... ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon at Monarch Dental® in Grapevine, ... deliver dental care in impoverished communities. Along with a team of fellow Smile ... help deliver care to over 550 individuals in need. , This outreach was hosted ...
(Date:8/9/2018)... ... , ... Thousands of US women with FDA-approved silicone gel ... The American Society of Plastic Surgeons (ASPS), The American Society for Aesthetic Plastic ... an MRI is recommended by FDA after the first three years then every ...
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... ... Jim and Kathy Coover and the company’s independent distributors, customers, and employees, the ... 24 hours of fundraising, exceeding the $2 million goal. 100 percent of the ...
(Date:8/3/2018)... ... August 03, 2018 , ... Firstaid4sport have been successfully selling ... the Firstaid4sport business in the 1990's and his son in law, Michael Davison ... providers in the UK of sports medicine products, supplying professional and amateur sports ...
(Date:8/2/2018)... ... 2018 , ... Allegheny Health Network (AHN) has ... and outside the network to vital patient imaging exams, saving valuable time and ... leading hospital systems nationwide in using lifeIMAGE, which expands access to patients’ medical ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 06, 2018 , ... Drs. ... in Clinton, MS using laser dentistry techniques. Using their BIOLASE WaterLase® dental laser, ... therapy called REPAIR Perio™. , Affecting the lives of millions of Americans, gum ...
(Date:8/7/2018)... ... August 07, 2018 , ... Braun Ambulances is honored to announce their ... Hutchison Convention Center in Dallas, Texas. Braun Ambulances will have four units on display ... , Fire Rescue International (FRI) is the International Association of Fire Chiefs’ (IAFC) ...
(Date:8/3/2018)... ... August 03, 2018 , ... Flexefits, a pioneer in ... 6199, especially for its allowing participants in Direct Primary Care arrangements to keep HSA ... (capped at $150 per individual and $300 per family per month.) , “We are ...
Breaking Medicine Technology: